Trial
NCT02539303
Delivery of Yamani-15/5 Chemical Solution for PAD
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
—
Condition
Peripheral Arterial Disease
Intervention
Yamani-15/5 chemical solution
Why stopped
Unable to enroll subjects
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-04